Skip to main content
. Author manuscript; available in PMC: 2024 May 2.
Published in final edited form as: Cell Rep. 2024 Mar 8;43(3):113934. doi: 10.1016/j.celrep.2024.113934

Figure 3. Colitic Wnt5 DKO mice develop splenomegaly.

Figure 3.

Mice were treated as in Figure 1, and samples were collected on day 7 of DSS treatment.

(A) Spleen weight is shown.

(B and C) The percentages of neutrophils and monocytes in the CD45+ population and their absolute numbers were determined by flow cytometry.

(D) The percentages of erythrocytes in the CD45− population and their absolute numbers were determined by flow cytometry.

(E) The percentages of megakaryocytes in the CD45−CD150+CD41+ population and their absolute numbers were determined by flow cytometry.

(F and G) The percentages of neutrophils, monocytes, and macrophages in the CD45+ population were determined by flow cytometry.

Data are presented as means ± SEM with p value (two-tailed one-way ANOVA for A; two-tailed Student’s t test for B–G). Each datum point represents one mouse. Each independent experiment consists of at least three technical replicates.

See also Figure S3.